Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Etoposide - Generic Drug Details

« Back to Dashboard

What are the generic sources for etoposide and what is the scope of etoposide freedom to operate?

Etoposide
is the generic ingredient in four branded drugs marketed by Teva Parenteral, Accord Hlthcare, Pierre Fabre, Hospira, Pharmachemie Bv, Watson Labs, Teva Pharms Usa, Mylan, Dava Pharms Inc, Watson Labs Inc, Corden Pharma, Fresenius Kabi Usa, West-ward Pharms Int, and Bristol Myers Squibb, and is included in eighteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for etoposide. Five suppliers are listed for this compound.

Summary for Generic Name: etoposide

Tradenames:4
Patents:1
Applicants:14
NDAs:18
Drug Master File Entries: see list11
Suppliers / Packagers: see list5
Bulk Api Vendors: see list97
Clinical Trials: see list455
Patent Applications: see list9,950
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:etoposide at DailyMed

Pharmacology for Ingredient: etoposide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dava Pharms Inc
VEPESID
etoposide
CAPSULE;ORAL019557-002Dec 30, 1986DISCNNoNo► Subscribe► Subscribe
Pierre Fabre
ETOPOSIDE
etoposide
INJECTABLE;INJECTION074813-001Jul 9, 1997DISCNNoNo► Subscribe► Subscribe
Bristol Myers Squibb
ETOPOPHOS PRESERVATIVE FREE
etoposide phosphate
INJECTABLE;INJECTION020906-001Feb 27, 1998DISCNNoNo► Subscribe► Subscribe
Corden Pharma
VEPESID
etoposide
INJECTABLE;INJECTION018768-001Nov 10, 1983DISCNYesNo► Subscribe► Subscribe
Mylan
ETOPOSIDE
etoposide
CAPSULE;ORAL075635-001Sep 19, 2001RXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot